NCT07086079View on ClinicalTrials.gov

A Study of Doravirine/Islatravir in Healthy Lactating Females (MK-8591A-061)

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 26, 2025

Primary Completion Date

June 1, 2026

Study Completion Date

June 1, 2026

Conditions
Healthy
Interventions
DRUG

DOR/ISL

Oral tablet

Trial Locations (1)

65802

RECRUITING

QPS Missouri ( Site 0001), Springfield

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY